Real-life ruxolitinib experience in intermediate-risk myelofibrosis

por Arikan, Fatma, Toptas, Tayfur, Atagunduz, Isik Kaygusuz, Ercan, Tarik, Oruc, Ozen, Yilmaz, Fergun, Tuglular, Tulin
Publicado 2021

Treosulfan-Based Conditioning Regimen for Second Allograft in Patients with Myelofibrosis

por Atagunduz, Isik Kaygusuz, Klyuchnikov, Evgeny, Wolschke, Christine, Janson, Dietlinde, Heidenreich, Silke, Christopeit, Maximilian, Ayuk, Francis, Kröger, Nicolaus
Publicado 2020